Literature DB >> 28416515

Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.

Sean M P Bennet1,2, Lena Böhn1,3, Stine Störsrud1,3, Therese Liljebo4, Lena Collin5, Perjohan Lindfors1,5,6, Hans Törnblom1,3, Lena Öhman1,2,7, Magnus Simrén1,3.   

Abstract

OBJECTIVE: The effects of dietary interventions on gut bacteria are ambiguous. Following a previous intervention study, we aimed to determine how differing diets impact gut bacteria and if bacterial profiles predict intervention response.
DESIGN: Sixty-seven patients with IBS were randomised to traditional IBS (n=34) or low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) (n=33) diets for 4 weeks. Food intake was recorded for 4 days during screening and intervention. Faecal samples and IBS Symptom Severity Score (IBS-SSS) reports were collected before (baseline) and after intervention. A faecal microbiota dysbiosis test (GA-map Dysbiosis Test) evaluated bacterial composition. Per protocol analysis was performed on 61 patients from whom microbiome data were available.
RESULTS: Responders (reduced IBS-SSS by ≥50) to low FODMAP, but not traditional, dietary intervention were discriminated from non-responders before and after intervention based on faecal bacterial profiles. Bacterial abundance tended to be higher in non-responders to a low FODMAP diet compared with responders before and after intervention. A low FODMAP intervention was associated with an increase in Dysbiosis Index (DI) scores in 42% of patients; while decreased DI scores were recorded in 33% of patients following a traditional IBS diet. Non-responders to a low FODMAP diet, but not a traditional IBS diet had higher DI scores than responders at baseline. Finally, while a traditional IBS diet was not associated with significant reduction of investigated bacteria, a low FODMAP diet was associated with reduced Bifidobacterium and Actinobacteria in patients, correlating with lactose consumption.
CONCLUSIONS: A low FODMAP, but not a traditional IBS diet may have significant impact on faecal bacteria. Responsiveness to a low FODMAP diet intervention may be predicted by faecal bacterial profiles. TRIAL REGISTRATION NUMBER: NCT02107625. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  DIET; INTESTINAL BACTERIA; IRRITABLE BOWEL SYNDROME

Mesh:

Year:  2017        PMID: 28416515     DOI: 10.1136/gutjnl-2016-313128

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  55 in total

Review 1.  Diet as Adjunctive Treatment for Inflammatory Bowel Disease: Review and Update of the Latest Literature.

Authors:  Oriana M Damas; Luis Garces; Maria T Abreu
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

Review 2.  The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models-Part I: Overview of Current Methods.

Authors:  Riley L Hughes; Maria L Marco; James P Hughes; Nancy L Keim; Mary E Kable
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

3.  Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome.

Authors:  Jørgen Valeur; Milada Cvancarova Småstuen; Torunn Knudsen; Gülen Arslan Lied; Arne Gustav Røseth
Journal:  Dig Dis Sci       Date:  2018-01-04       Impact factor: 3.199

Review 4.  The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models. Part II: Results.

Authors:  Riley L Hughes; Mary E Kable; Maria Marco; Nancy L Keim
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

Review 5.  Update on the Gastrointestinal Microbiome in Systemic Sclerosis.

Authors:  Chiara Bellocchi; Elizabeth R Volkmann
Journal:  Curr Rheumatol Rep       Date:  2018-06-25       Impact factor: 4.592

Review 6.  Microbiome at the Frontier of Personalized Medicine.

Authors:  Purna C Kashyap; Nicholas Chia; Heidi Nelson; Eran Segal; Eran Elinav
Journal:  Mayo Clin Proc       Date:  2017-12       Impact factor: 7.616

7.  Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.

Authors:  Ran Yan; Mandy Murphy; Angela Genoni; Evania Marlow; Ian C Dunican; Johnny Lo; Lesley Andrew; Amanda Devine; Claus T Christophersen
Journal:  BMJ Open Gastroenterol       Date:  2020-08

Review 8.  The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.

Authors:  Bruno P Chumpitazi
Journal:  Curr Opin Gastroenterol       Date:  2020-03       Impact factor: 3.287

9.  Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort.

Authors:  A Mack; J S Bobardt; A Haß; K B Nichols; R M Schmid; C K Stein-Thoeringer
Journal:  Gut Microbes       Date:  2019-12-06

Review 10.  Evidence-based and mechanistic insights into exclusion diets for IBS.

Authors:  Paul Moayyedi; Magnus Simrén; Premysl Bercik
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-02       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.